Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study.
Saved in:
| Title: | Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study. |
|---|---|
| Authors: | Himmler S; a Health Economics , WifOR , Darmstadt , Germany., Müller M; a Health Economics , WifOR , Darmstadt , Germany., Ostwald D; a Health Economics , WifOR , Darmstadt , Germany., Seddik A; a Health Economics , WifOR , Darmstadt , Germany., Basic E; b Health Technology Assessment & Outcomes Research , Pfizer Deutschland GmbH , Berlin , Germany., Hradetzky E; c Medical Affairs Internal Medicine , Pfizer Pharma GmbH , Berlin , Germany. |
| Source: | Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2019 Apr; Vol. 19 (2), pp. 223-230. Date of Electronic Publication: 2018 Oct 08. |
| Publication Type: | Comparative Study; Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-8379 |
|---|---|
| DOI: | 10.1080/14737167.2019.1522501 |
